Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial.

@article{BarraganRodrguez2008EfficacyAS,
  title={Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial.},
  author={L{\'a}zaro Barragan-Rodr{\'i}guez and Martha Rodr{\'i}guez-Moran and Fernando Guerrero‐Romero},
  journal={Magnesium research},
  year={2008},
  volume={21 4},
  pages={
          218-23
        }
}
To evaluate the efficacy and safety of oral magnesium supplementation, with magnesium chloride (MgCl2), in the treatment of newly diagnosed depression in the elderly with type 2 diabetes and hypomagnesemia. Twenty-three elderly patients with type 2 diabetes and hypomagnesemia were enrolled and randomly allocated to receive either 50 mL of MgCl2 5% solution equivalent to 450 mg of elemental magnesium or Imipramine 50 mg daily during 12 weeks. Widowhood or divorce in the last six months… 

Figures and Tables from this paper

Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response

Lower baseline HDRS scores, shorter history of disease, the presence of antidepressant-induced changes in the pharmaco-EEG profile at 6 h after treatment, and the fact of receiving treatment augmented with magnesium ions increased the odds of remission.

Role of magnesium supplementation in the treatment of depression: A randomized clinical trial

Current treatment options for depression are limited by efficacy, cost, availability, side effects, and acceptability to patients. Several studies have looked at the association between magnesium and

The Effect of Magnesium Supplementation on Primary Insomnia in the Elderly

Supplementation of magnesium appears to improve different measures effective in insomnia in the elderly, including sleep time, sleep efficiency, and concentration of serum renin, melatonin, and cortisol.

The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial

Background: Nearly 50% of older adults have insomnia, with difficulty in getting to sleep, early awakening, or feeling unrefreshed on waking. With aging, several changes occur that can place one at

The Effects of Magnesium Supplementation on Serum Magnesium and Calcium Concentration in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

It is demonstrated that magnesium supplementation significantly increased Serum magnesium levels which may have played an indirect role in improved clinical symptoms in patients with type 2 diabetes.

EFFECT OF MAGNESIUM SUPPLEMENTATION ON INDICES OF PSYCHOLOGICAL DISORDERS IN INSOMNIAC ELDERLY SUBJECTS: A DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL

Dietary magnesium supplementation brought about statistically significant decreases in GSI, PST, PSDI, ISI scores as well as somatization, anxiety, psychoticism, and depression symptoms and serum cortisol concentration in insomniac elderly subjects.

Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms

Vitamin D plus magnesium supplementation in obese women with mild to moderate depressive symptoms has beneficial influences on mood, serum levels of BDNF, inflammation, and SIRT1.

The Effects of Magnesium Supplementation on Lipid Profile Among Type 2 Diabetes Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials

A systematic review and meta-analysis of randomized controlled trials to assess the effects of magnesium (Mg) supplementation on the lipid profile in type 2 diabetes (T2DM) patients revealed that Mg supplementation did not have any effect on triglycerides, total cholesterol, TC, and high-density lipoprotein serum concentrations among T2DM patients in comparison with the control group.

Magnesium and mood disorders: systematic review and meta-analysis

The results provide little evidence for the involvement of Mg2+ in the mood disorders.
...

References

SHOWING 1-10 OF 28 REFERENCES

Plasma Magnesium and Calcium in Depression

An investigation into total and ionized plasma calcium and magnesium in a group of depressed patients both before and after recovery was reported.

Interactions between magnesium and psychotropic drugs.

The existent data sustain the idea that an increase of erythrocyte magnesium is involved in the mechanism of action of some psychotropic drugs.

Depression and Magnesium Deficiency

Serum magnesium should be determined when there are symptoms consistent with magnesium deficiency and/or in conditions which can lead to a deficiency, e.g., malabsorption, malnutrition, alcoholism and diuretic treatment.

The prevalence of comorbid depression in adults with diabetes: a meta-analysis.

The presence of diabetes doubles the odds of comorbid depression, and the prevalence of depression was significantly higher in diabetic women than in diabetic men, and in uncontrolled studies than in controlled studies.

Serum magnesium profile in heroin addicts: according to psychiatric comorbidity.

Gender modifies Mg levels in no comorbid subjects so that females show significantly lower Mg++ levels compared to males, and the presence of psychiatric comor bidity abates this difference.

Depression and poor glycemic control: a meta-analytic review of the literature.

Depression is associated with hyperglycemia in patients with type 1 or type 2 diabetes and additional studies are needed to establish the directional nature of this relationship and to determine the effects of depression treatment on glycemic control and the long-term course of diabetes.

Section III: Practical Considerations in the Management of Depression in Diabetes

While the mechanisms involved remain to be clarified, the story outlined in the preceding sections has evolved sufficiently to suggest that potential benefits of depression treatment likely surpass expected improvements in mood and quality of life.

Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes.

The interaction of depression and diabetes has a synergistic effect on the health of older Mexican Americans, increasing the risk for poor outcomes and finding this interaction was found to predict not only greater incidence but also earlier incidence of adverse events in older adults.

Rapid recovery from major depression using magnesium treatment.